Novartis Ag (NVSEF) Revenue Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Revenue Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	4.37%
Jun 30, 2024	1.24%
Dec 31, 2023	149.93%
Jun 30, 2023	-2.76%
Mar 31, 2023	8.85%
Dec 31, 2022	-61.43%
Sep 30, 2022	4.21%
Jun 30, 2022	0.87%
Mar 31, 2022	4.93%
Dec 31, 2021	-11.97%
Sep 30, 2021	3.86%
Jun 30, 2021	141.11%
Mar 31, 2021	8.26%
Dec 31, 2020	-91.79%
Sep 30, 2020	-91.96%
Jun 30, 2020	-83.05%
Mar 31, 2020	-93.07%
Jun 30, 2019	4,054.95%
Mar 31, 2019	1,851.63%
Dec 31, 2018	-97.92%